Clinical Trial Update: Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating Tulmimetostat (DZR123) in patients with mycosis fungoides and Sézary syndrome; the study is currently active but not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycosis Fungoides
• Sézary Syndrome

Drugs mentioned

• Tulmimetostat (DZR123) (Tulmimetostat)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Mycosis Fungoides, Sezary Syndrome | Phase 1 | Status: ACTIVE_NOT_RECRUITING